EXPRESSION OF GLYCOPROTEIN gD AND EVALUATION OF IMMUNE RESPONSE OF BOVINE HERPES VIRUS TYPE-1 IN BUFFALO

• Main Authors: Sumit Chowdhury, Goutam Roy, Bhaskar Sharma
• Format: Article
• Language: English
• Published: West Bengal Veterinary Alumni Association 2012-12-01
• Series: Exploratory Animal and Medical Research
• Subjects: BoHV-1; DNA Vaccine; gD glycoprotein; pBK-CMV-NSJ
• Online Access: http://www.animalmedicalresearch.org/Vol.2_Issue-2_December_2012/Sumit%20Chowdhury.pdf

Bovine Herpes Virus type-1 (BoHV-1) causes a multitude of clinical symptoms in cattle, buffaloes and small ruminants. No effective live attenuated or killed vaccine is currently available and extensive research work in progress towards the development of the subunit and genetically engineered vaccine. Since DNA vaccine is currently regarded as most important breakthrough in vaccinology, the present work was aimed at construction of DNA vaccine using most immunogenic glycoprotein gD and studying its immune response and protection in buffalo. gD specific DIG labelled probe was used to screen gD specific clones from cDNA library. The gD specific cloned plasmid was purified for eukaryotic expression. The SDS-PAGE & Western blot analysis showed the transient expression of the expected 71 kDa gD following transfection in COS-7 cells. Four seronegative buffalo calves were immunized at 0, 30 and 60 days with recombinant purified plasmid and two calves were kept as control. The result of SNT, ELISA and MTT indicate gene specific seroconversion and CMI response following immunization with plasmid. At 86 days of post first vaccination, animals were challenged with virulent BoHV-1 (216/IBR). Hematological picture of the control animals showed leucopenia and that was due to destruction of lymphocytes shown by TLC and apoptosis study. Vaccinated animals showed reduced virus shedding in terms of days post challenge as well as titers compared to the controls. Based on the above findings, we concluded that DNA based vaccine induces specific and protective immune responses to the buffalo.